Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 1118 - файл
.pdf
191
Ligation for Staged Hepatectomy : A New Minimally Invasive Two-Stage
https://t.me/med1917
Hepatectomy. Ann Surg Oncol. 2015; 22(8): 2787-8
35) Clemmesen JO Kondrup J Nielsen LB Larsen FS Ottet P. Effects of high-
volume plasmapheresis on ammonia, urea, and amino acids in patients with
acute liver failure. American Journal of Gastroenterology . 2001;96:1217–
1223.
36) Couinaud C. Le Foie: Etudes Anatomicales et Chirurgicales. Paris:
Masson & Cie; 1957: 187–208.
37) Davies N. et al. Effects of octreotide on liver regeneration and tumour
growth in the regenerating liver //Journal of gastroenterology and
hepatology. – 1997. – Vol. 12, №. 1. – P. 47-53.
38) Day CP, James OF. Steatohepatitis: a tale of two
“hits”? Gastroenterology. 1998;114:842–845. doi: 10.1016/S0016-
5085(98)70599-2.
39) de Liguori Carino N., O'Reilly D.A., Dajani K. Perioperative use of the
LiMON method of indocyanine green elimination measurement for the
prediction and early detection of post-hepatectomy liver failure. Eur. J.
Surg. Oncol. 2009;35:957–962.
40) Dejong CH, van de Poll MC, Soeters PB, Jalan R, Olde Damink SW.
Aromatic amino acid metabolism during liver failure. J Nutr. 2007;137
(Suppl.):1579–1585.
41) Eguchi H, Umeshita K, Sakon M, Nagano H, Ito Y, Kishimoto SI, et al.
Presence of active hepatitis associated with liver cirrhosis is a risk factor for
mortality caused by post-hepatectomy liver failure. Dig Dis
Sci. 2000;45:1383–1388.
42) Eipel C., Abshagen K., Vollmar B. Regulation of hepatic blood flow: the
hepatic arterial buffer response revisited //World J Gastroenterol. – 2010. –
Vol. 16, №. 48. – P. 6046-6057.
192
43) Emond J.C., Renz J.F., Ferrell L.D. Functional analysis of grafts from
https://t.me/med1917
living donors. Implications for the treatment of older recipients. Ann.
Surg. 1996;224:544–552. discussion 52-4.
44) Eshkenazy R. et al. Small for size liver remnant following resection:
prevention and management //Hepatobiliary surgery and nutrition. – 2014.
– Vol. 3, №. 5. – P. 303.
45) Fan S.T., Lai E.C., Lo C.M., Ng I.O., Wong J. Hospital mortality of
major hepatectomy for hepatocellular carcinoma associated with
cirrhosis. Arch. Surg. 1995;130:198–203.
46) Fan S.T., Lo C.M., Lai E.C., Chu K.M., Liu C.L., Wong J. Perioperative
nutritional support in patients undergoing hepatectomy for hepatocellular
carcinoma. N. Engl. J. Med. 1994;331:1547–1552.
47) Farantos C. et al. Effect of the portacaval shunt on reperfusion injury
after 65% hepatectomy in pigs //European Surgical Research. – 2008. – Vol.
40, №. 4. – P. 347-353.
48) Figueras J., Valls C., Rafecas A., Fabregat J., Ramos E., Jaurrieta E.
Resection rate and effect of postoperative chemotherapy on survival after
surgery for colorectal liver metastases. Br. J. Surg. 2001;88:980–985.
49) Finch R.J.B., Malik H.Z., Hamady Z.Z.R. Effect of type of resection on
outcome of hepatic resection for colorectal metastases. Br. J.
Surg. 2007;94:1242–1248.
50) Fondevila C. et al. Portal hyperperfusion: Mechanism of injury and
stimulus for regeneration in porcine small‐for‐size transplantation //Liver
Transplantation. – 2010. – Vol. 16, №. 3. – P. 364-374.
51) Fujii Y., Shimada H., Endo I. Risk factors of posthepatectomy liver
failure after portal vein embolization. J Hepatobiliary Pancreat.
Surg. 2003;10:226–232.
52) Gall T.M., Sodergren M.H., Frampton A.E., Fan R., Spalding D.R.,
Habib N.A., Pai M., Jackson J.E., Tait P, Jiao L.R. Radio-frequency-
193
assisted Liver Partition With Portal Vein Ligation (RALPP) for Liver
https://t.me/med1917
Regeneration. Ann Surg. 2015; 261(2): e45-6
53) Garcea G., Ong S. L., Maddern G. J. Predicting liver failure following
major hepatectomy //Digestive and Liver Disease. – 2009. – Vol. 41, №. 11.
– P. 798-806.
54) Garcea G., Ong S. L., Maddern G. J. Predicting liver failure following
major hepatectomy //Digestive and Liver Disease. – 2009. – Vol. 41, №. 11.
– P. 798-806.
55) Ghibellini G, Leslie EM, Pollack GM, Brouwer KL. Use of Tc-99m
mebrofenin as a clinical probe to assess altered hepatobiliary transport:
integration of in vitro, pharmacokinetic modeling, and simulation studies.
Pharm Res. 2008;25: 1851–1860.
56) Giovannini I, Chiarla C, Giuliante F, Vellone M, Ardito F, Sarno G, et
al. Analysis of the components of hypertransaminasaemia after liver
resection. Clin Chem Lab Med. 2007;45:357–360.
57) Giovannini I, Chiarla C, Giuliante F, Vellone M, Nuzzo G. Modulation
of plasma fibrinogen levels in acute-phase response after hepatectomy. Clin
Chem Lab Med. 2004;42:261–265.
58) Glanemann M. et al. Hyperperfusion syndrome in small-for-size livers
//European surgical research. – 2005. – Vol. 37, №. 6. – P. 335-341.
59) Glanemann M. et al. Hyperperfusion syndrome in small-for-size livers
//European surgical research. – 2005. – Vol. 37, №. 6. – P. 335-341.
60) Gluud LL, Christensen K, Christensen E, Krag A. Terlipressin for
hepatorenal syndrome. Cochrane Database Syst Rev. 2012;(9) CD005162.
61) Goldstein SL Somers MJ Baum MA Symons JM Brophy P. Pediatric
patients with multiple organ dysfunction syndrome receiving continuous
renal replacement therapy. Kidney Internattional . 2005;67:653–658.
62) Hashimoto M., Kothary P. C., Raper S. E. The effects of transforming
growth factor alpha and somatostatin on regenerating hepatocytes in the rat
//Regulatory peptides. – 1993. – Vol. 44, №. 1. – P. 49-59.
194
63) Hemming AW, Cattral MS. Ex vivo liver resection with replacement of
https://t.me/med1917
the inferior vena cava and hepatic vein replacement by transposition of the
portal vein. J Am Coll Surg 1999; 189 (5): 523–6.
64) Hemming AW, Chari RS, Cattral MS. Ex vivo liver resection. Can J Surg
2000; 43 (3): 222–4.
65) Hessheimer A. J. et al. Decompression of the portal bed and twice-
baseline portal inflow are necessary for the functional recovery of a “smallfor-size” graft //Annals of surgery. – 2011. – Vol. 253, №. 6. – P. 1201-
1210.
66) Hoekstra L.T., de Graaf W., Nibourg G.A. Physiological and
biochemical basis of clinical liver function tests: a review. Ann.
Surg. 2013;257:27–36.
67) Hong de F., Zhang Y.B., Peng S.Y., Huang D.S. Percutaneous
Microwave Ablation Liver Partition and Portal Vein Embolization for
Rapid Liver Regeneration: A Minimally Invasive First Step of ALPPS for
Hepatocellular Carcinoma. Ann Surg. 2016; 264(1): 1-2.
68) Honjo I., Kozaka S. Extensive resection of the liver in two stages. Rev
Int Hepatol. 1965; 15: 309–19.
69) Huguet C, Addario-Chieco P, Gavelli A, et al. Technique of hepatic
vascular exclusion for extensive liver resection. Am J Surg 1992; 163 (6):
602–5.
70) Ibrahim-zada I., Reid-Lombardo K., Murad M.H. Comparison of two-
stage hepatectomy and single-stage hepatectomy after downstaging by
chemotherapy for the treatment of initially unresectable colorectal liver
metastases: A meta-analysis. J Am Coll Surg. 2015; 28(2):55-62
71) Iida T. et al. Improvement of morphological changes after 70%
hepatectomy with portocaval shunt: preclinical study in porcine model
//Journal of Surgical Research. – 2007. – Vol. 143, №. 2. – P. 238-246.
195
72) Iida T. et al. Improvement of morphological changes after 70%
https://t.me/med1917
hepatectomy with portocaval shunt: preclinical study in porcine model
//Journal of Surgical Research. – 2007. – Vol. 143, №. 2. – P. 238-246.
73) Ikegami T. et al. Current concept of small-for-size grafts in living donor
liver transplantation //Surgery today. – 2008. – Vol. 38, №. 11. – P. 971-
982.
74) Imai K., Benitez C.C., Allard M.A., Vibert E., Cunha A.S., Cherqui D.,
Castaing D., Bismuth H., Baba H., Adam R. Failure to Achieve a 2stage Hepatectomy for Colorectal Liver Metastases: How to Prevent It?
Ann Surg. 2015; 262(5): 772-8;
75) Imamura H., Seyama Y., Kokudo N. One thousand fifty-six
hepatectomies without mortality in 8 years. Arch. Surg. 2003;138:1198–
1206. discussion 206.
76) Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, et
al. Improvement in perioperative outcome after hepatic resection: analysis
of 1803 consecutive cases over the past decade. Ann Surg. 2002;236:397–
406.
77) Kaibori M., Inoue T., Sakakura Y. Impairment of activation of
hepatocyte growth factor precursor into its mature form in rats with liver
cirrhosis. J. Surg. Res. 2002;106:108–114.
78) Kaneoka Y, Yamaguchi A, Isogai M, et al. Hepatic vein reconstruction
by external iliac vein graft using vascular clips. World J Surg 2000; 24 (3):
377–82.
79) Kaneoka Y, Yamaguchi A, Isogai M, et al. Hepatic vein reconstruction
by external iliac vein graft using vascular clips. World J Surg 2000; 24 (3):
377–82.
80) Karanjia N.D., Lordan J.T., Quiney N., Fawcett W.J., Worthington T.R.,
Remington J. A comparison of right and extended right hepatectomy with
all other hepatic resections for colorectal liver metastases: a ten-year
study. Eur. J. Surg. Oncol. 2009;35:65–70.
196
81) Kawasaki T., Murata S., Takahashi K. Activation of human liver
https://t.me/med1917
sinusoidal endothelial cell by human platelets induces hepatocyte
proliferation. J. Hepatol. 2010;53:648–654.
82) Kim J.M., Cho B.I., Kwon C.H. Hepatectomy is a reasonable option for
older patients with hepatocellular carcinoma. Am. J. Surg. 2015;209:391–
397.
83) Kim YI, Hwang YJ, Song KE, Yun YK, Lee JW, Chun BY. Hepatocyte
protection by a protease inhibitor against ischaemia/reperfusion injury of
human liver. J Am Coll Surg. 2002;195:41–50.
84) Kishi Y., Abdalla E.K., Chun Y.S. Three hundred and one consecutive
extended right hepatectomies: evaluation of outcome based on systematic
liver volumetry. Ann. Surg. 2009;250:540–548.
85) Kondrup J Almdal T Vilstrup H Tygstrup N. High volume plasma
exchange in fulminant hepatic failure. International Journal of Artificial
Organs . 1992;15:669–676.
86) Krishnamurthy S, Krishnamurthy GT. Technetium-99m-iminodiacetic
acid organic anions: review of biokinetics and clinical application in
hepatology. Hepatology. 1989;9:139–153. 65. Krishnamurthy GT,
Krishnamurthy S. Cholescintigraphic measurement of liver function: how
is it different from other methods? Eur J Nucl Med Mol Imaging.
2006;33:1103–1106.
87) Kubota K, Makuuchi M, Sugawara Y et al. Reconstruction of the hepatic
and portal veins using a patch graft from the right ovarian vein. Am J Surg.
1998;176(3):295-297. 4. Nakamura S, Sakaguchi S, Kitazawa T et al.
Hepatic vein reconstruction for preserving remnant liver function. Arch
Surg. 1990;125(11):1455-1459.
88) Kwon AH, Matsui Y, Ha-Kawa SK, Kamiyama Y. Functional hepatic
volume measured by technetium-99m-galactosyl-human serum albumin
liver scintigraphy: comparison between hepatocyte volume and liver
volume by computed tomography. Am J Gastroenterol. 2001;96:541–546.
197
89) Laleman W Wilmer A Evenepoel P Elst IV Zeegers M. Effect of the
https://t.me/med1917
molecular adsorbent recirculating system and Prometheus devices on
systemic haemodynamics and vasoactive agents in patients with acute-onchronic alcoholic liver failure. Critical Care . 2006;10
90) Lam C.M., Fan S.T., Lo C.M., Wong J. Major hepatectomy for
hepatocellular carcinoma in patients with an unsatisfactory indocyanine
green clearance test. Br. J. Surg. 1999;86:1012–1017.
91) Lam V.W., Laurence J.M., Johnston E., Hollands M.J., Pleass H.C.,
Richardson A.J. A systematic review of two-stage hepatectomy in patients
with initially unresectable colorectal liver metastases. HPB (Oxford). 2013;
15(7): 483-91.
92) Lan AK, Luk HN, Goto S, Chen SM, Eng HL, Chen YS, et al. Stress
response to hepatectomy in patients with a healthy or a diseased liver. World
J Surg. 2003;27:761–764.
93) Lavranos G., Nikolaou A., Angelopoulou R. Octreotide inhibits liver
regeneration by suppressing regional estrogen receptor type a expression
//Hellenic journal of nuclear medicine. – 2013. – Vol. 17. – P. 56-61.
94) Lesurtel M., Graf R., Aleil B. Platelet-derived serotonin mediates liver
regeneration. Science. 2006;312:104–107.
95) Li C., Mi K., Wen T.-F., Yan L.-N., Li B. Safety of patients with a graft
to body weight ratio less than 0.8% in living donor liver transplantation
using right hepatic lobe without middle hepatic vein. HepatoGastroenterology. 2012;59:469–472.
96) Little S.A., Jarnagin W.R., DeMatteo R.P., Blumgart L.H., Fong Y.
Diabetes is associated with increased perioperative mortality but equivalent
long-term outcome after hepatic resection for colorectal cancer. J.
Gastrointest. Surg. 2002;6:88–94.
97) Little SA, Jarnagin WR, DeMatteo RP, Blumgart LH, Fong Y. Diabetes
is associated with increased perioperative mortality but equivalent longterm
198
outcome after hepatic resection for colorectal cancer. J Gastrointest
https://t.me/med1917
Surg. 2002;6:88–94.
98) Lodge JP, Ammori BJ, Prasad KR, et al. Ex vivo and in situ resection of
inferior vena cava with hepatectomy for colorectal metastases. Ann Surg
2000; 231 (4): 471–9.
99) Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histology in
obese patients undergoing bariatric surgery. J Hepatol. 2006;45:600–606.
doi: 10.1016/j.jhep.2006.06.013.
100) Madariaga JR, Fung J, Gutierrez J, et al. Liver resection combined with
excision of vena cava. J Am Coll Surg 2000; 191 (3): 244–50.
101) Makuuchi M, Hasegawa H, Yamazaki S, et al. Four new hepatectomy
procedures for resection of the right hepatic vein and preservation of the
inferior right hepatic vein. Surg Gynecol Obstet 1987; 164 (1): 68–72.
102) Makuuchi M., Kosuge T., Takayama T. Surgery for small liver
cancers. Semin. Surg. Oncol. 1993;9:298–304.
103) Makuuchi M., Kosuge T., Takayama T. Surgery for small liver
cancers. Semin. Surg. Oncol. 1993;9:298–304.
104) Makuuchi M., Takayasu K., Takuma T., Yamazaki S., Hasegawa H.,
Nishimura S., Shimamura Y. Preoperative transcatheter embolization of the
portal venous branch for patients receiving extended lobectomy due to the
bile duct carcinoma. J Jpn Soc Clin Surg. 1984; 45: 14-20.
105) Mann DV, Lam WW, Hjelm NM, So NM, Yeung DK, Metreweli C, et
al. Metabolic control patterns in acute phase and regenerating human liver
determined in vivo by 31-phosphorus magnetic resonance
spectroscopy. Ann Surg. 2002;235:408–416.
106) Matrella E. et al. Bolus somatostatin but not octreotide reduces hepatic
sinusoidal pressure by a NO‐independent mechanism in chronic liver
disease //Alimentary pharmacology & therapeutics. – 2001. – Vol. 15, №.
6. – P. 857-864.
199
107) Matsumoto K., Yoshitomi H., Rossant J., Zaret K.S. Liver organogenesis
https://t.me/med1917
promoted by endothelial cells prior to vascular
function. Science. 2001;294:559–563.
108) Melendez J, Ferri E, Zwillman M, et al. Extended hepatic resection: a 6-
year retrospective study of risk factors for perioperative mortality. J Am
Coll Surg 2001; 192 (1): 47–53.
109) Merkel C. et al. Effect of somatostatin on splanchnic hemodynamics in
patients with liver cirrhosis and portal hypertension //Digestion. – 1985. –
Vol. 32, №. 2. – P. 92-98.
110) Michalopoulos G.K. Liver regeneration. J. Cell. Physiol. 2007;213:286–
300.
111) Mimura T, Hamazaki K, Sakai H, Tanaka N, Mimura H. Evaluation of
hepatic functional reserve in rats with obstructive jaundice by
asyaloglycoprotein receptor. Hepatogastroenterology. 2001;48:777–782.
112) Mitsumori A, Nagaya I, Kimoto S, et al. Preoperative evaluation of
hepatic functional reserve following hepatectomy by technetium-99m
galactosyl human serum albumin liver scintigraphy and computed
tomography. Eur J Nucl Med. 1998;25:1377–1382.
113) Mitzner SR Stange J Klammt S Risler T Erley CM. Improvement of
hepatorenal syndrome with extracorporeal albumin dialysis MARS: results
of a prospective, randomized, controlled clinical trial. Liver Transplantation
. 2000;6:277–286.
114) Mortensen K.E., Conley L.N., Nygaard I. Increased sinusoidal flow is
not the primary stimulus to liver regeneration. Comp. Hepatol. 2010;9:2.
115) Moug SJ, Smith D, Wilson IS, Leen E, Horgan PG. The renal sequelae
of a novel triphasic approach to blood loss reduction during hepatic
resection. Eur J Surg Oncol. 2006;32:435–438.
116) Mullen J.T., Ribero D., Reddy S.K. Hepatic insufficiency and mortality
in 1,059 noncirrhotic patients undergoing major hepatectomy. J. Am. Coll.
Surg. 2007;204:854–862. discussion 62–4.
200
117) Muratore A, Ribero D, Ferrero A, Bergero R, Capussotti L. Prospective
https://t.me/med1917
randomized study of steroids in the prevention of ischaemic injury during
hepatic resection with pedicle clamping. Br J Surg. 2003;90:17–22.
118) N.L. Bucher. Insulin, glucagon, and the liver. Adv. Enzym.
Regul.;15:221-230.
119) Nakae H Asanuma Y Tajimi K. Cytokine removal by plasma Exchange
with continuous hemodiafiltration in critically ill patients. Therapeutic
Apheresis . 2002;6:419–424.
120) Nakamura S, Sakaguchi S, Kitazawa T, et al. Hepatic vein reconstruction
for preserving remnant liver function. Arch Surg 1990; 125 (11): 1455–9.
121) Nakamura S, Tsuzuki T. Surgical anatomy of the hepatic veins and the
inferior vena cava. Surg Gynecol Obstet 1981; 152 (1): 43–50.
122) Nanashima A, Yamaguchi H, Shibasaki S, Abo T, Morino S, Yoshinaga
M, et al. Changes of branched chain amino acids and tyrosine ratio (BTR)
after hepatectomy. Acta Med Nagasaki. 2003;48:29–33.
123) Nobuoka T. et al. Portal blood flow regulates volume recovery of the rat
liver after partial hepatectomy: molecular evaluation //European surgical
research. – 2006. – Vol. 38, №. 6. – P. 522-532.
124) Okabayashi T, Hnazaki K, Nishimori I, Sugimoto T, Maeda H, Yatabe
T, et al. Continuous postoperative blood glucose monitoring and control
using a closed-loop system in patients undergoing hepatic resection. Dig
Dis Sci. 2008;53:1405–1410.
125) Orii R, Sugawara Y, Hayashida M, Uchida K, Yamada Y, Takayama T,
et al. Lactate is correlated with the indocyanine green elimination rate in
liver resection for cirrhotic patients. Anesth Analg. 2001;92:1064–1070.
126) Ozdemir FN Tutal E Sezer S Gür G Bilgic A. Effect of supportive
extracorporeal treatment in liver transplantation recipients and advanced
liver failure patients. Hemodialysis International . 2006;10:S28–S32.
127) Papalampros E. et al. Liver pathology and cell proliferation after
octreotide administration following partial hepatectomy in rats: an
Соседние файлы в папке @xirurgi_2025